Meny

Javascript is not activated in your browser. This website needs javascript activated to work properly.
Du är här

Detection of pancreatic cancer using antibody microarray-based serum protein profiling

Författare:
Publiceringsår: 2008
Språk: Engelska
Sidor: 2211-2219
Publikation/Tidskrift/Serie: Proteomics
Volym: 8
Nummer: 11
Dokumenttyp: Artikel
Förlag: WILEY-VCH Verlag GmbH & Co.

Sammanfattning

The driving force behind oncoproteomics is to identify protein signatures that are associated with a particular malignancy. Here, we have used a recombinant scFv antibody microarray in an attempt to classify sera derived from pancreatic adenocarcinoma patients versus healthy subjects. Based on analysis of nonfractionated, directly labeled, whole human serum proteomes we have identified a protein signature based on 19 nonredundant analytes, that discriminates between cancer patients and healthy subjects. Furthermore, a potential protein signature, consisting of 21 protein analytes, could be defined that was shown to be associated with cancer patients having a life expectancy of <12 months. Taken together, the data suggest that antibody microarray analysis of complex proteomes will be a useful tool to define disease associated protein signatures.

Disputation

Nyckelord

  • Medicine and Health Sciences

Övriga

Published
Yes
  • ISSN: 1615-9861

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen